6687-87-2

Basic information

• Product Name: diethyl (3,4-dihydroquinolin-1(2H)-ylmethylidene)propanedioate
• Synonyms: Diethyl (3,4-dihydroquinolin-1(2H)-ylmethylene)malonate; propanedioic acid, 2-[(3,4-dihydro-1(2H)-quinolinyl)methylene]-, diethyl ester
• CAS NO: 6687-87-2
• Molecular Formula: C₁₇H₂₁NO₄
• Molecular Weight: 303.3529
• Mol File: 6687-87-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 380.8°C at 760 mmHg
• Flash Point: 184.1°C
• Density: 1.201g/cm³
• Vapor Pressure: 5.31E-06mmHg at 25°C
• Refractive Index: 1.582
• CAS DataBase Reference: diethyl (3,4-dihydroquinolin-1(2H)-ylmethylidene)propanedioate(CAS DataBase Reference)
• NIST Chemistry Reference: diethyl (3,4-dihydroquinolin-1(2H)-ylmethylidene)propanedioate(6687-87-2)
• EPA Substance Registry System: diethyl (3,4-dihydroquinolin-1(2H)-ylmethylidene)propanedioate(6687-87-2)

Safety Data

• Hazardous Substances Data: 6687-87-2(Hazardous Substances Data)

Upstream product

• 635-46-1 1,2,3,4-tetrahydroisoquinoline 
• 87-13-8 diethyl 2-ethoxymethylenemalonate 

Downstream Products

• 797785-46-7 10-(2-benzyloxy-ethylamino)-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid ethyl ester 
• 42835-54-1 1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid 

Relevant articles and documents

MACROLONES

A compound of formula (I) or a pharmaceutically acceptable derivative thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.

NOVEL 14 AND 15 MEMBERED-RING COMPOUNDS

The present invention relates to 14- or 15-membered macrolides substituted at the 4" position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.

NOVEL 14 AND 15 MEMBERRED-RING COMPOUNDS

The present invention relates to 14- or 15-membered macrolides substituted at the 4" position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.